Covid-19 Vaccine Covaxin Phase 3 Trial: No Adverse Effects After First Dose, Says Gujarat Hospital Official


Covaxin, vaccine trial, bharat biotech, india's first independent covid019 vaccine, covid vaccine update, vaccine trial in gujarat updates, visit to Pm narendra modi vaccine facilityFive volunteers have signed up for the phase 3 trials of Covaxin and were vaccinated with the first dose on Thursday. (File photo)

Covaxin Coronavirus Vaccine Update: Volunteers given a dose of Covaxin vaccine have yet to complain of any health problems or symptoms, said a Gujarat-based hospital official, who is conducting a phase 3 trial of the Covid-19 vaccine. The phase 3 trial of Covaxin, India’s first indigenous Covid-19 vaccine developed by Bharat Biotech in collaboration with the Indian Council for Medical Research (ICMR), started yesterday at Sola Civil Hospital, Ahmedabad.

According to the Medical Superintendent of the Sola Civil Hospital, Dr. Parul Bhatt, more volunteers will be vaccinated today. Five volunteers have signed up for the trial and were vaccinated from the 10 volunteers who approached them for the trial. In addition, he informed that if any adverse reaction occurs to the volunteers of the vaccine, they will be treated in the hospital.

A total of 1,000 volunteers have been enrolled, who will be vaccinated with 500 doses that arrived at the Gujarat facility on November 24 and have been stored at a temperature between 2 and 8 degrees Celsius. Although the study design says that volunteers in the 18-99 age group can be screened, Bhatt added that only volunteers between the ages of 18 and 60 have been included at this time.

Volunteers with comorbidities such as heart disease, hypertension, ischemic, diabetes can be included if they have had stable vital signs in the last three months, but not those with autoimmune diseases. Furthermore, anyone who has already been infected with the Covid-19 infection once or a family member has it while residing in the same household cannot be attacked.

Injections of the intramuscular vaccine will be administered to one participant, twice within a 30 minute interval at the site, followed by another dose within the next 24 hours. If no adverse reaction occurs, a follow-up dose will be given on day 15 and the fourth on day 28, Bhatt told The Indian Express.

Meanwhile, Prime Minister Narendra Modi is scheduled to visit Bharat Biotech’s Genome Valley facility in Hyderabad on Saturday.

Get Live Stock Prices from BSE, NSE, US Market & Latest NAV, Mutual Fund Portfolio, Calculate Your Taxes with Income Tax Calculator, Learn Top Winners, Top Losers, and Top market capital funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay up to date with the latest news and updates from Biz.

.